Homocysteine and folate as risk factors for dementia and Alzheimer disease

American Journal of Clinical Nutrition

Volumn 82, Issue 3, 2005, Pages 636-643

  Ravaglia, Giovanni ^a   Forti, Paola ^a   Maioli, Fabiola ^a   Martelli, Mabel ^a   Servadei, Lucia ^a   Brunetti, Nicoletta ^a   Porcellini, Elisa ^b   Licastro, Federico ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alzheimer disease; Dementia; Folate; Homocysteine; Incidence

Indexed keywords

APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; AGING; BLOOD; COGNITION; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; ITALY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR;

AGED; AGING; ALZHEIMER DISEASE; COGNITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; ITALY; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 27244445944     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn.82.3.636     Document Type: Article

References (40)

1. Leifer B. Early diagnosis of Alzheimer's disease: clinical and economic benefits. J Am Geriatr Soc 2003;51:S281-8.
2. Lipton Sa, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997;94:5923-8.
3. Krugman II, Kumaravel TS, Lohani A, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002;22:1752-62.
4. Sai X, Kawamura Y, Kokame K, Yamaguchi H, et al. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J Biol Chem 2002;277:12915-20.
5. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA 2002;288:2015-22.
6. Kalaria R. Similarities between Alzheimer's disease and vascular dementia. J Neurol Sci 2002;203-204:29-34.
7. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32.
8. Calvaresi E, Bryan J. B vitamins, cognition, and aging: a review. J Gerontol Psychol Sci Soc Sci 2001;56:P327-39.
9. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer Disease. Arch Neurol 1998;55:1449-55.
10. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-9.
11. Lehman M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10:12-20.
12. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine, folate, and vitamin B12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004;80:114-22.
13. Prins ND, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly. The Rotterdam Scan Study. Neurology 2002;1375-80.
14. Budge M, Johnston C, Hogervorst E, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000;903:407-10.
15. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003;77:668-73.
16. Riggs KM, Spiro A, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-14.
17. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
18. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004;62:1972-6.
19. Ravaglia G, Forti P, Maioli F, et al. Education, occupation, and prevalence of dementia: findings from the Conselice study. Dement Geriatr Cogn Disord 2002;14:90-100.
20. Ravaglia G, Forti P, Maioli F, et al. Conselice study: a population based survey of brain aging in a municipality of the Emilia Romagna region (A.U.S.L. Ravenna). Design and methods Arch Gerontol Geriatr 2001;33(suppl):313-24.
21. Valente C, Maione P, Lippi A, et al. Validation of the Mini-Mental State Examination (MMSE) as a screening instrument for dementia in an Italian population. Giorn Gerontol 1992;40:161-5.
22. Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M. Mini-Mental State Examination: a normative study in an Italian elderly population. Eur J Neurol 1996;3:1-5.
23. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996;36:378-84.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
25. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzhimer's Disease. Neurology 1984;34:939-44.
26. Licastro F, Pedrini S, Ferri C, et al. Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol 2000;48:388-91.
27. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
28. Herrmann W, Quast S, Ullrich M, Schultze H, Bodis M, Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 1999;144:91-100.
29. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
30. McCaddon A, Hudson P, Davies G, Hughes A, Williams JHH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-13.
31. Kalmjin S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MMB. Total homocysteine and cognitive decline in a community-based sample of elderly subjects. The Rotterdam Study. Am J Epidemiol 1999;150:283-9.
32. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
33. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
34. Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M. Homocysteine in cerebral macroangiopathy and microangiopathy. Lancet 1999;353:1586-7.
35. Hajjar K. Homocysteine: a sulph'rous fire. J Clin Invest 2001;107:663-4.
36. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002;58:1471-5.
37. Borroni B, Agosti C, Panzali AF, Di Luca M, Padovani A. Homocysteine, vitamin B6, and vascular disease in patients with AD. Neurology 2002;59:1475-6.
38. Storey SG, Suryadevara V, Aronow WS, Ahn C. Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease. J Gerontol Med Sci 2003;58:M1135-6.
39. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 2001;56:1188-94.
40. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet and cardiovascular diseases. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.